Terms: = Endocrine gland cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
12 results:
1. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
[TBL] [Abstract] [Full Text] [Related]
2. Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.
Xu J; Lyu S; Zhao Y; Zhang X; Liu Z; Zhao X; He Q
Technol Cancer Res Treat; 2022; 21():15330338221078438. PubMed ID: 35138217
[No Abstract] [Full Text] [Related]
3. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer.
Huang P; Zhang Y; Chen J; Shentu W; Sun Y; Yang Z; Liang T; Chen S; Pu Z
Oncotarget; 2015 Aug; 6(24):20241-51. PubMed ID: 26036312
[TBL] [Abstract] [Full Text] [Related]
5. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
[TBL] [Abstract] [Full Text] [Related]
6. The calcium sensing receptor: from understanding parathyroid calcium homeostasis to bone metastases.
Mihai R
Ann R Coll Surg Engl; 2008 May; 90(4):271-7. PubMed ID: 18492387
[TBL] [Abstract] [Full Text] [Related]
7. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract] [Full Text] [Related]
8. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract] [Full Text] [Related]
9. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000.
Chow SM; Law SC; Au SK; Mang O; Yau S; Yuen KT; Lau WH
Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):329-36. PubMed ID: 14524486
[TBL] [Abstract] [Full Text] [Related]
10. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors.
Tropé C; Kaern J; Vergote IB; Kristensen G; Abeler V
Gynecol Oncol; 1993 Nov; 51(2):236-43. PubMed ID: 8276300
[TBL] [Abstract] [Full Text] [Related]
11. Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1992 May; 168(5):260-9. PubMed ID: 1598660
[TBL] [Abstract] [Full Text] [Related]
12. Somatostatinoma: a case report and review of the literature.
Harris GJ; Tio F; Cruz AB
J Surg Oncol; 1987 Sep; 36(1):8-16. PubMed ID: 3041116
[TBL] [Abstract] [Full Text] [Related]
